Amgen

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

Yesterday

Amgen To Present At Citi's 2025 Virtual Oncology Leadership Summit PR Newswire (Press Release)21:01 14-Feb-25

In the last 7 days

Ex-Dividend Reminder: Amgen, MMM and Provident Financial Services Nasdaq18:11 12-Feb-25

HyClone Seeks to Quash Amgen’s Subpoena Issued in Denosumab BPCIA Litigation Against Fresenius JD Supra17:36 11-Feb-25

3 Fabulous Dividend Stocks to Buy in February The Motley Fool19:34 9-Feb-25

Similar Survival, Safety for Bevacizumab Biosimilar vs Originator in Colorectal Cancer Center for Biosimilars12:22 8-Feb-25

In the last month

EU Biosimilar Regulatory and Launch Updates JD Supra21:21 7-Feb-25

Amgen To Present At The 35th Annual Oppenheimer Healthcare Life Sciences Conference Amgen (Press Release)21:05 7-Feb-25

Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead Benzinga17:35 5-Feb-25

Amgen expands global capability centre in Hyderabad with 500,000 sq ft lease The Economic Times09:52 5-Feb-25

Amgen Optimistic About Growth, Despite Denosumab Biosimilars, Potential Tariffs Scrip Pharma Intelligence02:31 5-Feb-25

Amgen Surpasses Q4 Earnings Forecasts The Motley Fool22:10 4-Feb-25

Amgen Earnings Report: Q4 Overview Benzinga21:45 4-Feb-25

Amgen profit beats estimates, next MariTide studies start by mid-year Yahoo! US21:13 4-Feb-25

AMGN Named A Top Socially Responsible Dividend Stock Nasdaq13:41 3-Feb-25

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.38 Simply Wall St17:52 1-Feb-25

Amgen Announces Webcast Of 2024 Fourth Quarter And Full Year Financial Results Amgen (Press Release)23:31 31-Jan-25

Amgen’s Blincyto granted EC approval for new acute lymphoblastic leukaemia indication PMLiVE12:36 31-Jan-25

Federal Court rules on patent listing again, confirms generic not required to address patent submitted before ANDS… JD Supra20:14 30-Jan-25

European Commission Approves Blincyto® In Philadelphia Chromosome-Negative CD19-Positive B-Cell … PR Newswire (Press Release)21:10 29-Jan-25

Celltrion and Amgen Reach Settlement in Prolia® / Xgeva® Biosimilar Litigation JD Supra19:55 29-Jan-25

Amgen and Celltrion Settle Denosumab BPCIA Case JD Supra17:53 29-Jan-25

Amgen opens new drug substance facility in North Carolina, US Pharmaceutical Technology09:21 27-Jan-25

[JPM2025] Celltrion will sell cheap biosimilar for osteoporosis prophylaxis. How will original drug maker Amgen respond? Korea Biomedical Review05:04 20-Jan-25

Amgen gets colorectal cancer okay for KRAS drug pharmaphorum19:23 18-Jan-25

Amgen Launches Wezlana™ as the First Stelara® Interchangeable Biosimilar through Optum’s Nuvaila JD Supra17:47 17-Jan-25

Amgen’s Lumakras/Vectibix approved by FDA to treat metastatic colorectal cancer PMLiVE12:37 17-Jan-25

view more headlines

14 Feb 21:01

Amgen

Biotech Top Stories

UK Top Stories

World Top Stories